Clinical Trial Update: Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for a study of novel anti-leukemia agents used in Flu/Mel reduced-intensity conditioning transplant for myeloid malignancies, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloid Malignancies

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Myeloid Malignancy, Hematologic Malignancy | Phase 1 | Status: RECRUITING